BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 22, 2013
View Archived Issues
Novel lung cancer-related gene fusions associated with oncogenic potential and drug-sensitivity
Read More
Tensha Therapeutics begins trial of BET bromodomain inhibitor TEN-010
Read More
Kyowa Hakko Kirin begins international phase III study of istradefylline
Read More
Phase II results for CSL-112 as a potential treatment for atherothrombotic disease
Read More
PaxVax initiates phase I trial to investigate two adenovirus anthrax vector candidate vaccines
Read More
Myriad Genetics forms second HRD test collaboration with BioMarin
Read More
Abilify Maintena approved in E.U. for maintenance treatment of schizophrenia
Read More
DSR-85955 as a new mineralocorticoid receptor antagonist
Read More
MPO inhibitor PF-1355 demonstrates significant attenuation of cardiovascular and renal disorders
Read More
Oncolytics Biotech reports topline data from Reolysin study in head and neck cancer
Read More
AstraZeneca presents a potent, novel progesterone receptor antagonist
Read More
Yale University presents novel antibody recruiting molecules for cancer
Read More
Researchers at Pfizer synthesize novel BACE1/2 inhibitors for Alzheimer's disease
Read More
Preclinical combinatorial kinase inhibition of genetic mutation-based cancer growth
Read More
Merck & Co. synthesizes new CETP inhibitors
Read More
Spirogen and UCL Business disclose new agents for bacterial infections
Read More
Vivione Biosciences enters into CRADA to expand the capability of RAPID-B
Read More
Arrayit enters agreement with Diagnostic Oncology Research Organization
Read More
DM-1992 shows promising plasma concentration-time profiles in phase II trials
Read More
Onoact 50 approved in Japan for new indication
Read More
New phase I/II study to explore trametinib and palbociclib for melanoma
Read More
Capricor Therapeutics formed through merger of Capricor and Nile Therapeutics
Read More
Avastin approved in Japan for ovarian cancer
Read More
Non-small cell lung cancer treatment Xalkori receives regular FDA approval
Read More
Eylea approved in Japan for macular edema secondary to central retinal vein occlusion
Read More
Paxil tablets approved for post-traumatic stress disorder in Japan
Read More
